Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Diane Holdford"'
Autor:
Anthony Ricco, Nitai Mukhopadhyay, Xiaoyan Deng, Diane Holdford, Vicki Skinner, Siddharth Saraiya, Drew Moghanaki, Mitchell S. Anscher, Michael G. Chang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundIn this phase I/II trial, 5-year physician-assessed toxicity and patient reported quality of life data is reported for patients undergoing moderately hypofractionated intensity modulated radiation therapy (IMRT) for prostate cancer using a
Externí odkaz:
https://doaj.org/article/6f33bb4195e04c809dae592f1b1e0dbb
Autor:
A. Ricco, Drew Moghanaki, Michael G. Chang, Nitai D. Mukhopadhyay, Diane Holdford, Vicki Skinner, Mitchell S. Anscher, Siddharth Saraiya, Xiaoyan Deng
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Background In this phase I/II trial, 5-year physician-assessed toxicity and patient reported quality of life data is reported for patients undergoing moderately hypofractionated intensity modulated radiation therapy (IMRT) for prostate cancer using a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ca6350f64f90ca320212af2efe955d
https://doi.org/10.21203/rs.3.rs-28814/v1
https://doi.org/10.21203/rs.3.rs-28814/v1
Autor:
Arun J. Sanyal, Michael G. Chang, Mitchell S. Anscher, Aiping Wang, Nitai D. Mukhopadhyay, M. Rosu, Baruch M. Grob, Drew Moghanaki, Diane Holdford, Ross B. Mikkelsen, Vicki Skinner
Publikováno v:
American Journal of Clinical Oncology. 41:544-548
PURPOSE Physician reported symptomatic late rectal injury occurs in about 5% to 25% of patients treated with radiation therapy for prostate cancer, depending on the treatment technique. Patients, however, report clinically meaningful declines in bowe
Autor:
Nitai D. Mukhopadhyay, Drew Moghanaki, A. Ricco, Michael G. Chang, Vicki Skinner, Mitchell S. Anscher, Xiaoyan Deng, Siddharth Saraiya, Diane Holdford
Publikováno v:
Journal of Clinical Oncology. 38:299-299
299 Background: This study reports the 5 year toxicity and efficacy data of a phase I/II trial of moderately hypofractionated intensity modulated radiation therapy (IMRT) for localized prostate cancer utilizing a simultaneous integrated boost and pel
Autor:
Diane Holdford, Theresa Cooley, Megan Mackey, Andra Krauze, Joanna Shih, Michal G Chang, Lindsay Rowe, Philip J. Tofilon, Kevin Camphausen
Background Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor activity shown to enhance overall survival and progression free survival in patients with newly diagnosed glioblastoma (GBM). This reports on the late toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383e27d695df205761c0e4a04c066e71
https://europepmc.org/articles/PMC6213944/
https://europepmc.org/articles/PMC6213944/
Autor:
Andra Krauze, Diane Holdford, Mark R. Gilbert, Michael Chang, Sharon M. Smith, Lindsay Rowe, Kevin Camphausen, Sten Myrehaug, Joanna Shih, Howard A. Fine, Philip J. Tofilon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f117fe58d81958df9ca8c3fc6156977
https://europepmc.org/articles/PMC5693051/
https://europepmc.org/articles/PMC5693051/
Autor:
Lindsay Rowe, Sten Myrehaug, Joanna Shih, S. Smith, Andra Krauze, Diane Holdford, Philip J. Tofilon, K. Camphausen, Michael G. Chang, Howard A. Fine, Mark R. Gilbert
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:S100-S101
Autor:
Nitai D. Mukhopadhyay, Arun J. Sanyal, Vicki Skinner, Mitchell S. Anscher, B. Mayer Grob, Drew Moghanaki, Aiping Wang, M. Rosu, Michael G. Chang, Diane Holdford, Ross B. Mikkelsen
Publikováno v:
Acta oncologica (Stockholm, Sweden). 55(12)
Autor:
Nitai D. Mukhopadhyay, Arun J. Sanyal, V. Skinner, Diane Holdford, B.M. Grob, Mitchell S. Anscher, Drew Moghanaki, Ross B. Mikkelsen, M.G. Chang, M. Rosu
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:E261-E262
Autor:
Andra Krauze, Philip J. Tofilon, Joanna Shih, Michael G. Chang, Kevin Camphausen, Howard A. Fine, Diane Holdford, Sten D. Myrehaug, Sharon M. Smith
Purpose Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor (HDACi) activity shown to sensitize glioblastoma (GBM) cells to radiation in preclinical models. We evaluated the addition of VPA to standard radiation therapy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08871d15a2af89ecdf53047215f41bea
https://europepmc.org/articles/PMC4510472/
https://europepmc.org/articles/PMC4510472/